Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Pfizer
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
EXTENSION STUDY FOR SUBJECTS WITH CHRONIC MYELOID LEUKEMIA (CML) WHO HAVE PREVIOUSLY PARTICIPATED IN BOSUTINIB STUDIES B1871006 OR B1871008
• To allow long term bosutinib treatment in subjects with chronic or advanced phases Ph+ CML who received bosutinib in a previous Pfizer sponsored CML study (ie, studies B1871006 and B1871008) and who...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pfizer Global Research and Development
Update Il y a 4 ans
Linezolid vs. Vancomycin/Oxacillin/Dicloxacillin in the Treatment of Catheter-Related Gram Positive Bloodstream Infections
The primary objective of this study is to compare the microbiological efficacy of linezolid to vancomycin/oxacillin/dicloxacillin in the empiric treatment of patients with gram-positive catheter-relat...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
A safety and efficacy study of pregabalin in children 4-16 years of age for partial onset seizures
The primary objective of this study is to evaluate the efficacy of 2 dose levels of pregabalin (Level 1: 2.5 mg/kg/day; maximum 150 mg day and Level 2: 10 mg/kg/day; maximum 600 mg day) compared to p...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer España
Update Il y a 4 ans
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF PREGABALIN IN SUBJECTS WITH GENERALIZED ANXIETY DISORDER (GAD) SWITCHING FROM BENZODIAZEPINE THERAPY Estudio multicéntrico, aleatorizado, doble ciego, controlado con placebo de cambio a Pregabalina en sujetos con trastorno de ansiedad generalizada (TAG) que recibían anteriormente tratamiento con Benzodiazepina
To evaluate the efficacy of pregabalin in maintaining the benzodiazepine -free state in subjects with prior stable alprazolam use.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Pfizer
Update Il y a 4 ans
Étude B9991003 : étude de phase 3, randomisée évaluant l’avelumab (msb0010718c) en association avec l’axitinib (Inlyta®) par rapport au sunitinib (Sutent®) en monothérapie, comme traitement de première ligne, chez des patients ayant un carcinome à cellules rénales avancé. [essai clos aux inclusions]
Le carcinome à cellules rénales est le type le plus fréquent de cancer du rein. Au stade avancé ou métastatique, le traitement se fait par des chimiothérapies ciblées et/ou des immunothérapies associ...
Country
France
organs
Rein
Specialty
Thérapies Ciblées
,
Immunothérapie - Vaccinothérapie
Essai clos aux inclusions
More information
Man Max 99 years
Pfizer Inc
Update Il y a 4 ans
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF SUNITINIB PLUS PREDNISONE VERSUS PREDNISONE IN PATIENTS WITH PROGRESSIVE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER AFTER FAILURE OF A DOCETAXEL-BASED CHEMOTHERAPY REGIMEN
To demonstrate superiority in the overall survival (OS) of patients with progressive mCRPC treated with sunitinib plus prednisone (SP) versus placebo plus prednisone (PP) after failure of a docetaxel-...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
PHASE 3, MULTICENTER, LONG-TERM OBSERVATIONAL STUDY OF SUBJECTS FROM TANEZUMAB STUDIES WHO UNDERGO A TOTAL KNEE, HIP OR SHOULDER REPLACEMENT ESTUDIO OBSERVACIONAL A LARGO PLAZO, MULTICÉNTRICO, FASE III, EN PACIENTES DE ESTUDIOS CON TANEZUMAB QUE SE SOMETEN A UNA SUSTITUCIÓN TOTAL DE RODILLA, CADERA U HOMBRO
To describe the post-operative outcome of subjects who underwent a total knee, hip,or shoulder replacement while participating in tanezumab Study A4091056, A4091057 or A4091058 (treatment period and s...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
A PHASE 2, RANDOMIZED, PLACEBO CONTROLLED, DOUBLE BLIND PROOF-OF-CONCEPT STUDY OF THE EFFICACY AND SAFETY OF PF-02545920 IN SUBJECTS WITH HUNTINGTON’S DISEASE
• To assess the efficacy of 26-week oral daily dosing with PF-02545920 on motor function in subjects with HD.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Inc
Update Il y a 4 ans
A continuation study of CPG 7909 Injection in patients with matastatic or recurrent malignancies who have stable disease or who have responded to CPG 7909 Injection therapy
To allow patients who have completed a clinical trial with CPG 7909 Injection or have reached a maximum number of cycles with a combination product (such as chemotherapy) to continue treatment with CP...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA
Update Il y a 4 ans
A clinical trial of axitinib plus PF-04856884 or axitinib alone for patients with metastatic renal cancer who have already been treated with an anti-VEGF agent
Part I: To confirm that the combination of PF-04856884 and AG-013736 is safe and tolerable at the doses to be used in Part II of the study. Part II: To document clinical activity of the combination...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
4
5
6
7
8
9
10
11
12
13
Next